Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

405
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
405
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

437
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
437
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

442
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
442
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

2.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

397
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
397
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

261
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
261

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Underutilization of Osteoporosis Screening in Patients With Severe COPD and Long Term Corticosteroid Use.

Journal of primary care & community health·2026
Same author

Renal Venous Hypertension and Kidney Dysfunction: Implications for Clinical Practice.

Cardiology in review·2026
Same author

Sotatercept for pulmonary arterial hypertension on background therapy: a systematic review and meta-analysis of randomized controlled trials.

Proceedings (Baylor University. Medical Center)·2026
Same author

My Patient Has Episodic Dyspnea: Should I Order Spirometry With Bronchodilators?

Chest·2025
Same author

Commentary on manuscript entitled "Association of vasoactive active-inotropic score and poor outcomes in patients who underwent coronary artery bypass grafting: Systematic review and meta-analysis" in press <i>Perfusion</i>.

Perfusion·2025
Same author

Glucocorticoids in Diuretic Resistance: An Emerging Approach for Heart Failure.

Cardiology in review·2025

Related Experiment Video

Updated: Jan 2, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Cardiogenic Pulmonary Edema.

Logan Dobbe1, Rubayat Rahman2, Mohamed Elmassry2

  • 1Department of Graduate Medical Education, Madigan Army Medical Center, Tacoma, Washington.

The American Journal of the Medical Sciences
|December 10, 2019
PubMed
Summary
This summary is machine-generated.

Cardiogenic pulmonary edema involves high capillary pressures leading to fluid buildup in the lungs. Pulmonary ultrasound aids in early detection and management of this condition.

Keywords:
Capillary permeabilityCardiogenic pulmonary edemaPentoxifyllinePulmonary surfactant-associated protein BUltrasonography

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

725

Related Experiment Videos

Last Updated: Jan 2, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K
A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

725

Area of Science:

  • Cardiology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Cardiogenic pulmonary edema stems from hemodynamic congestion and elevated capillary pressures.
  • Increased capillary pressure disrupts alveolar-capillary barriers, increasing fluid leakage and impairing gas exchange.
  • Surfactant dysfunction and atelectasis can occur, complicating the condition.

Purpose of the Study:

  • To review the pathophysiology and diagnostic challenges of cardiogenic pulmonary edema.
  • To highlight the utility of pulmonary ultrasound in detecting and characterizing pulmonary edema.
  • To discuss conventional and potential alternative management strategies.

Main Methods:

  • Review of existing literature on cardiogenic pulmonary edema.
  • Discussion of hemodynamic principles and fluid dynamics in pulmonary edema.
  • Evaluation of diagnostic tools, including pulmonary ultrasound.
  • Analysis of current and proposed therapeutic interventions.

Main Results:

  • Elevated capillary pressures are central to cardiogenic pulmonary edema development.
  • Pulmonary ultrasound is a sensitive tool for detecting pulmonary edema, especially in decompensated patients.
  • Elevated surfactant protein B levels may indicate barrier disruption and persist post-treatment.

Conclusions:

  • Pulmonary ultrasound offers advantages over routine clinical assessment for identifying pulmonary edema.
  • Characterizing patient subgroups with pulmonary ultrasound may guide alternative management strategies.
  • Beta agonists and pentoxifylline represent potential alternative treatments warranting further investigation.